tiprankstipranks
Trending News
More News >
Qyuns Therapeutics Co., Ltd. Class H (HK:2509)
:2509
Hong Kong Market

Qyuns Therapeutics Co., Ltd. Class H (2509) Income Statement

Compare
1 Followers

Qyuns Therapeutics Co., Ltd. Class H Income Statement

Last quarter (Q2 2025), Qyuns Therapeutics Co., Ltd. Class H's total revenue was ¥103.24M, an increase of 359.69% from the same quarter last year. In Q2, Qyuns Therapeutics Co., Ltd. Class H's net income was ¥-14.17M. See Qyuns Therapeutics Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 158.79M¥ 14.75M¥ 9.66M¥ 21.35M
Gross Profit
¥ 92.19M¥ 14.75M¥ -25.85M¥ -9.56M
Operating Expenses
¥ 418.56M¥ 504.51M¥ 352.67M¥ 180.71M
Depreciation and Amortization
¥ 30.46M¥ 32.28M¥ 28.65M¥ 23.70M
EBITDA
¥ -311.82M¥ -484.12M¥ -295.51M¥ -155.65M
Operating Income
¥ -326.37M¥ -504.51M¥ -293.69M¥ -168.62M
Other Income/Expenses
¥ -23.39M¥ -16.82M¥ -18.69M¥ -257.92M
Pretax Income
¥ -349.76M¥ -521.33M¥ -312.38M¥ -426.54M
Net Income
¥ -335.57M¥ -507.75M¥ -298.19M¥ -411.04M
Per Share Metrics
Basic EPS
¥ -1.53¥ -2.47¥ -1.56¥ -1.62
Diluted EPS
¥ -1.53¥ -2.47¥ -1.56¥ -1.62
Weighted Average Shares Outstanding
219.44M 205.67M 222.07M 222.07M
Weighted Average Shares Outstanding (Diluted)
219.44M 205.67M 222.07M 222.07M
Currency in CNY

Qyuns Therapeutics Co., Ltd. Class H Earnings and Revenue History